Neoral

Neoral 100mg Capsules are indicated for the below;


Transplantation indications:


Solid organ transplantation


Prevention of graft rejection following solid organ transplantation.
Treatment of transplant cellular rejection in patients previously receiving other immunosuppressive agents.


Bone marrow transplantation


Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation.
Prevention or treatment of graft-versus-host disease (GVHD).


Non-transplantation indications:


Endogenous uveitis


Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects.
Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations.


Nephrotic syndrome


Steroid-dependent and steroid-resistant nephrotic syndrome, due to primary glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis, or membranous glomerulonephritis.
Neoral can be used to induce and maintain remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids.


Rheumatoid arthritis


Treatment of severe, active rheumatoid arthritis.


Psoriasis


Treatment of severe psoriasis in patients in whom conventional therapy is inappropriate or ineffective.


Atopic dermatitis


Neoral is indicated in patients with severe atopic dermatitis when systemic therapy is required.

Available on request.

Available on request.